Skip to main content
DCOY
NASDAQ Life Sciences

Decoy Files $50M Shelf While Carrying Going-Concern Warning and Nasdaq Delisting Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.975
Mkt Cap
$2.326M
52W Low
$0.9
52W High
$16.92
52W Position info
8.4% above low
Off High info
94% below high
Rel. Volume
Market data snapshot near publication time

DCOY is trading near its 52-week low of $0.9 (8.4% above the low).

Summary

Decoy Therapeutics filed a $50 million universal shelf registration, giving it capacity to sell securities from time to time — no shares sold yet. The filing lands while the company carries a going-concern warning, cash runway only into early 2027, and active Nasdaq delisting risk.


Key Events · Financing and Capital Events · DCOY

  • New $50M Universal Shelf Filed

    A Form S-3 registers up to $50,000,000 of common stock, preferred stock, warrants, debt securities and units for sale from time to time. No securities have been sold under it; each tranche requires a prospectus supplement.

  • Float Caps Practical Raise

    Public float is approximately $2,525,022 based on 2,385,282 shares outstanding, of which only 68,748 are held by non-affiliates. Under General Instruction I.B.6, primary sales are limited to one-third of float in any 12-month period while float stays below $75 million.

  • Going-Concern Warning Restated

    Substantial doubt about the ability to continue as a going concern is stated in the filing, with existing cash and equivalents sufficient to fund operations only into early 2027.

  • Nasdaq Delisting Overhang

    A Mandatory Panel Monitor through March 31, 2027 applies to the company, and the stayed $5 million MVLS Rule could, if approved, delist the stock with no compliance or cure period.


Analysis · DCOY · Life Sciences

Decoy has registered the capacity to sell up to $50 million of stock, preferred, warrants, debt or units from time to time — no shares have been sold, and each actual tranche needs its own prospectus supplement. That headline size dwarfs the company itself: with a public float of roughly $2.5 million and only 68,748 shares held by non-affiliates, General Instruction I.B.6 caps primary sales at one-third of float in any 12-month window, so the practical raise is a small fraction of the stated amount. What lifts this above a routine shelf is the backdrop the filing restates — substantial doubt about the ability to continue as a going concern, cash said to last only into early 2027, a Nasdaq Mandatory Panel Monitor running through March 31, 2027, and a stayed $5 million market-value listing rule that, if approved, could delist the stock with no cure period. Any drawdown on this shelf will be heavily dilutive to a very thin float, and the company needs capital to keep operating.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DCOY was trading at $0.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.90 to $16.92. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DCOY - Latest Insights

DCOY
Nov 12, 2026, 6:31 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.980 info
Change: -$0.075 (-7%) info
Market Cap: $2.326M info
DCOY
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.980 info
Change: -$0.075 (-7%) info
Market Cap: $2.326M info
DCOY
Oct 16, 2026, 4:07 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $0.980 info
Change: -$0.190 (-16%) info
Market Cap: $2.326M info
DCOY
Oct 07, 2026, 4:59 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $0.980 info
Change: -$0.6186 (-39%) info
Market Cap: $2.326M info
DCOY
Sep 23, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.99
Real-time Price: $0.980 info
Change: -$3.01 (-75%) info
Market Cap: $2.326M info